Lana Medical Company Stock: price and insider trades · Saudi Arabia
Lana Medical Company: what insiders have been doing
Lana Medical Company has a thin disclosure history in our data (latest filing: 14 October 2026). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by Tadawul (CMA). They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 18,386 of 26,911 companies
39.4
score / 100
Value40
Quality39
FCF yld-11%
Earn yld2.9%
EV/EBITDA10.3x
ROE·
Gross mgn23%
Net mgn2.9%
Debt/EBITDA2.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SAR 1.90
Analyst consensus
Income statement
RevenueSAR 92.3M
Gross profitSAR 20.8M23% margin
EBITDASAR 12M13% margin
Net incomeSAR 2.7M2.6% margin
Valuation
PER (trailing)38.0x
P/Book1.5x
Beta0.02
Balance sheet & cash
Market capSAR 102.6M
Total debtSAR 29.1M
Free Cash Flow-SAR 10.4M
Debt / Equity63%
Profitability & ownership
% insiders19.1%
% institutions0.0%
Last declaration on 14 October 2026
Declarations1 total
- ●Executives0Tadawul
1 of 1 declaration
About Lana Medical Company
LANA is a company operating in the XSAU market, specializing in financial services. It provides tailored solutions to meet the needs of its clients in the financial sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations